<p>
    Mayo Protocol for Hilar Cholangiocarcinoma:
</p>
<p>
    Hilar cholangiocarcinoma often involves the bile duct at the liver hilum, making surgical resection difficult. This protocol uses <strong>neoadjuvant therapy</strong> before liver transplantation to control tumor growth, sterilize the tumor bed, and prevent recurrence.
</p>
<p>
    <strong>When to Use:</strong>
</p>
<ul>
    <li data-list-item-id="e51d20ff8bc3f0b8b8e38a3a313ba4820">
        <strong>Unresectable hilar cholangiocarcinoma</strong> &lt; 3 cm
    </li>
    <li data-list-item-id="e22e60b0952fbd5246bf5a845b5fd6cf1">
        Diagnosis confirmed by:
        <ul>
            <li data-list-item-id="e5270d946dd66fe5b4464def65d0901b0">
                Imaging (CT/MRI/MRCP) <strong>and</strong>
            </li>
            <li data-list-item-id="e5daab7589b90a791f1ac89d7d0eaed03">
                Pathology from brush cytology, biopsy, or FISH (aneuploidy)
            </li>
            <li data-list-item-id="ebce91422232506b747428b921da6525c">
                OR CA 19-9 &gt; 100 if histology not possible
            </li>
        </ul>
    </li>
</ul>
<p>
    <strong>Do NOT Use If (Exclusion Criteria)</strong>
</p>
<ul>
    <li data-list-item-id="e2c271f14a03bc4c372fc1b831356c1f3">
        Disease outside the hilum on imaging
    </li>
    <li data-list-item-id="e6400bc4393ae3b64d63b272906684826">
        Previous chemotherapy or radiation therapy
    </li>
    <li data-list-item-id="ea45378f9524a72f4600f62dbbe6892e0">
        Uncontrolled infection
    </li>
    <li data-list-item-id="e5402ae60345065281aadf803a614a126">
        Major prior biliary surgery or resection attempt
    </li>
    <li data-list-item-id="e2e117c98aa72e0e2f38b65c52caae63e">
        Advanced local disease (vascular encasement, contralateral atrophy, extension below cystic duct)
    </li>
    <li data-list-item-id="e90268808b0e4e97d210c58a723aeaf01">
        Evidence of metastases on staging
    </li>
</ul>
<p>
    <strong>Step-by-Step Protocol</strong>
</p>
<p>
    1. <strong>Neoadjuvant External Beam Radiation</strong>
</p>
<ul>
    <li data-list-item-id="ec3870052e5908d850f08ec646d9c0819">
        45 Gy in 30 fractions (1.5 Gy twice daily over 3 weeks)
    </li>
    <li data-list-item-id="e13e91dbec964868244c3c61026c72d7e">
        Continuous 5-fluorouracil (5-FU) infusion during radiation
    </li>
    <li data-list-item-id="ec5232b7a9bcc2b7fcfdf127871dae875">
        Rationale: controls local disease and sensitizes tumor to radiation
    </li>
</ul>
<p>
    2. <strong>Brachytherapy </strong>(2 weeks later)
</p>
<ul>
    <li data-list-item-id="e3a985882a6f50eb10e2fc61a97546788">
        20 Gy at 1 cm depth over ~20â€“25 hours
    </li>
    <li data-list-item-id="e3fc669f8e344f9e2c9ef96b2103d11a4">
        Delivered directly to bile duct tumor via catheter
    </li>
    <li data-list-item-id="eb82aa6f34716b6197463c1afe7ceb08c">
        Rationale: delivers high dose to tumor while sparing surrounding tissue
    </li>
</ul>
<p>
    3. <strong>Capecitabine Maintenance</strong>
</p>
<ul>
    <li data-list-item-id="e810f5a328cc6ec2eaa0443435c82325b">
        Oral chemotherapy until transplant (pause during perioperative staging)
    </li>
    <li data-list-item-id="e2a20491cadd7b7abde21a4ae7fdaa0a8">
        Rationale: continued suppression of microscopic disease
    </li>
</ul>
<p>
    4. <strong>Pre-Transplant Staging Surgery</strong>
</p>
<ul>
    <li data-list-item-id="e8181e08d0776ca0a64c444adb22ab049">
        Laparotomy near transplant date (day before living donor transplant or before deceased donor offer)
    </li>
    <li data-list-item-id="e8509a798502b4e6ca63e79ff5629124f">
        Purpose: rule out occult metastases or peritoneal spread
    </li>
    <li data-list-item-id="e7b92f2a6e96e4f259baa3a797f94e127">
        If positive, <strong>transplant is aborted</strong>
    </li>
</ul>
<p>
    5. <strong>Liver Transplant</strong>
</p>
<ul>
    <li data-list-item-id="e1e8fa230c72624b7cd07616040a658d8">
        Performed only if staging is negative for metastases or progression
    </li>
</ul>
<p>
    <strong>Key Monitoring</strong>
</p>
<ul>
    <li data-list-item-id="e6ce5307cce579eac99acfcf699e3099d">
        Imaging at regular intervals to confirm no progression
    </li>
    <li data-list-item-id="e63f1247b58a5b819ee678db5f21c5375">
        Laboratory tumor markers (CA 19-9)
    </li>
    <li data-list-item-id="ed3518a360b573d971151fd6416e3f365">
        Toxicity monitoring for chemotherapy and radiation&nbsp;
    </li>
</ul>